Process for the treatment or prevention of herpes

Abstract

The present invention related to the use of at least one active ingredient of the flavonoid family in the preparation of compositions for the treatment and/or prevention of herpes.

We claim: 
     
       1. A method for treating or preventing herpes, comprising administering to a patient in need thereof an anti-herpes treatment, the active component of which consists of a flavonoid heteroside selected from the group consisting of hesperidin, diosmin and combinations thereof. 
     
     
       2. The method of claim 1, wherein said flavonoid heteroside is administered orally. 
     
     
       3. The method of claim 2, wherein said flavonoid heteroside is admixed and administered in unit dosage form. 
     
     
       4. The method of claim 2, wherein said flavonoid heteroside is hesperidin, the latter being admixed and administered in unit dose form comprising from 20-800 mg of hesperidin. 
     
     
       5. The method of claim 2, wherein said flavonoid heteroside is hesperidin the latter being administered in the form of an aqueous dispersion. 
     
     
       6. The method of claim 1, wherein said flavonoid heteroside is administered topically. 
     
     
       7. The method of claim 6, wherein said flavonoid heteroside is hesperidin in the form of a composition consisting of 5% hesperidin dispersed in a hydrophilic base. 
     
     
       8. The method of claim 1, wherein said flavonoid heteroside is in the form of a dermocosmetic composition. 
     
     
       9. The method of claim 1, wherein said flavonoid heteroside is in the form of a pharmaceutical composition. 
     
     
       10. The method of claim 1, wherein said flavonoid heteroside is in the form of a cream, ointment, lotion, eye wash or solid stick.